stoxline Quote Chart Rank Option Currency Glossary
  
Invizyne Technologies Inc. Common Stock (IZTC)
16.5  1 (6.45%)    02-11 16:00
Open: 15.1734
High: 17
Volume: 12,043
  
Pre. Close: 15.5
Low: 15.1734
Market Cap: 157(M)
Technical analysis
2025-02-14 4:49:09 PM
Short term     
Mid term     
Targets 6-month :  23.1 1-year :  26.98
Resists First :  19.78 Second :  23.1
Pivot price 15.66
Supports First :  13.86 Second :  10.19
MAs MA(5) :  16.69 MA(20) :  14.44
MA(100) :  0 MA(250) :  0
MACD MACD :  0.8 Signal :  0.6
%K %D K(14,3) :  58.3 D(3) :  64.4
RSI RSI(14): 55.8
52-week High :  23 Low :  8.75
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ IZTC ] has closed below upper band by 40.3%. Bollinger Bands are 0% narrower than normal.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 17.01 - 17.11 17.11 - 17.21
Low: 14.95 - 15.06 15.06 - 15.17
Close: 16.32 - 16.49 16.49 - 16.66
Company Description

Invizyne Technologies, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was founded in 2014 and is headquartered in Monrovia, California.

Headline News

Wed, 12 Feb 2025
Rebranding Invizyne to eXoZymes Signifies a Sustainable - GlobeNewswire

Wed, 12 Feb 2025
From Lab to Factory: AI-Engineered 'Exozymes' Promise Weeks-Fast Chemical Production Revolution - StockTitan

Tue, 11 Feb 2025
Invizyne Technologies, Inc. will Change its Ticker to EXOZ from IZTC -February 12, 2025 at 12:00 am EST - Marketscreener.com

Mon, 10 Feb 2025
Invizyne Technologies Announces Name Change to eXoZymes, Inc. and New Ticker Symbol - The Manila Times

Mon, 10 Feb 2025
Major Biotech Rebrand: Invizyne Becomes eXoZymes - Strategic Move in Enzyme Manufacturing Space - StockTitan

Thu, 14 Nov 2024
Invizyne Technologies Completes $15M IPO, Makes NASDAQ Debut Under IZTC - StockTitan

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 0 (M)
Shares Float 10 (M)
Held by Insiders 0 (%)
Held by Institutions 76.3 (%)
Shares Short 10 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -4.68e+006
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin 704 %
Return on Assets (ttm) 833.6 %
Return on Equity (ttm) -88.3 %
Qtrly Rev. Growth -700 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth -0.7 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -4 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow -0
Stock Dividends
Dividend 0
Forward Dividend 23200
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android